Literature DB >> 9397995

Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat.

A A Nanji1, D Zakim, A Rahemtulla, T Daly, L Miao, S Zhao, S Khwaja, S R Tahan, A J Dannenberg.   

Abstract

We investigated the potential of dietary saturated fatty acids to decrease endotoxemia and suppress expression of cyclooxygenase 2 (Cox-2) and tumor necrosis factor alpha (TNF-alpha) in established alcohol-induced liver injury. Six groups (five rats/group) of male Wistar rats were studied. Rats in group 1 were fed a fish oil-ethanol diet for 6 weeks. Rats in groups 2, 3, and 4 were fed fish oil and ethanol for 6 weeks. Ethanol administration was stopped at this time, and the rats were switched to isocaloric diets containing dextrose with fish oil (group 2), palm oil (group 3), or medium-chain triglycerides (group 4) as the source of fat for an additional 2 weeks. Rats in groups 5 and 6 were fed fish oil-ethanol and fish oil-dextrose, respectively, for 8 weeks. Liver samples were analyzed for histopathology, lipid peroxidation, and levels of messenger RNA (mRNA) for Cox-2 and TNF-alpha. Concentrations of endotoxin were determined in plasma. The most severe inflammation and fibrosis were detected in groups 1 and 5, as were the highest levels of endotoxin, lipid peroxidation, and mRNA for Cox-2 and TNF-alpha. After ethanol was discontinued, there was minimal histological improvement in group 2 but near normalization of the histology, including regression of fibrosis, in groups 3 and 4. Histological improvement was associated with decreased levels of endotoxin, lipid peroxidation, and reduced expression of Cox-2 and TNF-alpha. The data indicate that a diet enriched in saturated fatty acids (groups 3 and 4) effectively reverses alcohol-induced liver injury, including fibrosis. The therapeutic effects of saturated fatty acids may be explained, at least in part, by reduced endotoxemia and lipid peroxidation, which in turn result in decreased levels of TNF-alpha and Cox-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397995     DOI: 10.1002/hep.510260622

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing.

Authors:  Monique Allman; Latausha Gaskin; Chantal A Rivera
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

Review 2.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

3.  Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats.

Authors:  Ya-Ling Chen; Hsiang-Chi Peng; Xiang-Dong Wang; Suh-Ching Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

4.  Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats.

Authors:  Wei Zhong; Qiong Li; Guoxiang Xie; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-10       Impact factor: 4.052

5.  Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan.

Authors:  Ya-Ling Chen; Li-Ju Chen; Ming-Jong Bair; Mei-Lan Yao; Hsiang-Chi Peng; Sien-Sing Yang; Suh-Ching Yang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

6.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

Authors:  Min You; Robert V Considine; Teresa C Leone; Daniel P Kelly; David W Crabb
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 7.  Saturated fat, carbohydrate, and cardiovascular disease.

Authors:  Patty W Siri-Tarino; Qi Sun; Frank B Hu; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

Review 8.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera; LaTausha Gaskin; Monique Allman; Jia Pang; Kristen Brady; Patrick Adegboyega; Kevin Pruitt
Journal:  BMC Gastroenterol       Date:  2010-05-28       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.